The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis
- 1 May 1994
- journal article
- clinical trial
- Published by Springer Nature in Calcified Tissue International
- Vol. 54 (5) , 381-384
- https://doi.org/10.1007/bf00305523
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunoassay for urinary pyridinoline: The new marker of bone resorptionJournal of Bone and Mineral Research, 1993
- Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's diseaseJournal of Bone and Mineral Research, 1993
- Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.BMJ, 1991
- Effect of Menopause and Hormone Replacement Therapy on the Urinary Excretion of Pyridinium Cross-LinksJournal of Clinical Endocrinology & Metabolism, 1991
- Screening procedure for women at risk of developing postmenopausal osteoporosisOsteoporosis International, 1990
- Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseaseBone and Mineral, 1990
- PREDICTION OF RAPID BONE LOSS IN POSTMENOPAUSAL WOMENThe Lancet, 1987
- CYPROTERONE ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL OESTROGEN/GESTAGEN THERAPYClinical Endocrinology, 1987
- An easy and reliable method for determination of urinary hydroxyprolineClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatographyAnalytical Biochemistry, 1984